(function(){ var content_array=["
關于Gene Solutions<\/b> <\/p> \n
Gene Solutions 是一家亞洲跨國生物科技公司,在利用先進的人工智能 (AI) 和 ctDNA 技術提供創新癌癥檢測解決方案方面處于領先地位。公司與東南亞 4,500 多家醫院和診所合作,擁有一支由約 250 名生物學專家和技術人員組成的專業團隊,員工總數達 700 人。<\/p> \n
Gene Solutions 已發表 50 多篇同行評審的論文,并開展了 50 多項多中心研究,其自主研發成果以及位于新加坡和越南的 CAP 認證的新一代測序 (NGS) 實驗室備受認可。該公司將多維基因組學與AI驅動分析方法相結合,推動癌癥診療模式的革新。<\/p> \n
參考文獻<\/b> <\/p> \n
(1) GLOBOCAN 2020 – Global Cancer Observatory, Lung Cancer Statistics<\/p> \n
(2) Lam, D. C.-L.; Liam, C.-K.; Andarini, S.; Park, S.; Tan, D. S. W.; Singh, N.; Jang, S. H.; Vardhanabhuti, V.; Ramos, A. B.; Nakayama, T.; Nhung, N. V.; Ashizawa, K.; Chang, Y.-C.; Tscheikuna, J.; Van, C. C.; Chan, W. Y.; Lai, Y.-H.; Yang, P.-C. Lung Cancer Screening in Asia: An Expert Consensus Report. Journal of Thoracic Oncology 2023, 18 (10), 1303–1322.<\/p> \n
(3)數據來源:美國癌癥協會(ACS)《2022癌癥事實與數據》和《2021癌癥事實與數據》;ACS網站;國際癌癥研究機構網站。<\/p> \n
(4) Infante, M. V.; Cardillo, G. Lung Cancer Screening in Never-Smokers: Facts and Remaining Issues. Eur Respir J<\/i>2020<\/b>, 56<\/i> (5), 2002949.<\/p> \n
(5) Kim, R. Y. Insights Into Opportunistic Lung Cancer Screening for Individuals Who Have Never Smoked. JAMA Netw Open 2025, 8 (1), e2454009.<\/p> \n
(6) Loh, C. H.; Koh, P. W.; Ang, D. J. M.; Lee, W. C.; Chew, W. M.; Koh, J. M. K. Characteristics of Singapore Lung Cancer Patients Who Miss out on Lung Cancer Screening Recommendations. Singapore Medical Journal 2024, 65 (5), 279–287.<\/p> \n
(7) Kakinuma, R.; Muramatsu, Y.; Asamura, H.; Watanabe, S.; Kusumoto, M.; Tsuchida, T.; Kaneko, M.; Tsuta, K.; Maeshima, A. M.; Ishii, G.; Nagai, K.; Yamaji, T.; Matsuda, T.; Moriyama, N. Low-Dose CT Lung Cancer Screening in Never-Smokers and Smokers: Results of an Eight-Year Observational Study. Transl Lung Cancer Res 2020, 9 (1), 10–22.<\/p> \n
(8) Pinsky PF. Lung cancer screening with low-dose CT: a world-wide view. Transl Lung Cancer Res. 2018 Jun;7(3):234–242. doi: 10.21037\/ tlcr.2018.05.12<\/p> \n
(9)中華人民共和國國家衛生健康委員會。(2024年8月27日)。國家衛生健康委辦公廳關于印發《肺癌篩查與早診早治方案(2024年版)》的通知。醫療應急司。<\/p> \n
(10) Martin, M. D.; Kanne, J. P.; Broderick, L. S.; Kazerooni, E. A.; Meyer, C. A. Lung-RADS: Pushing the Limits. RadioGraphics 2017, 37 (7), 1975–1993.<\/p> \n
(11) Nguyen, et. al. (2025) Prospective validation study: a non-invasive circulating tumor DNA-based assay for<\/p> \n
(12) Nguyen, V. T. C., et al. (2025). Cost-effective shallow genome-wide sequencing for profiling plasma cfDNA signatures to enhance lung cancer detection. Future Oncology, 1–12.<\/p> \n